Literature DB >> 20617115

Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))].

Xiaoyuan Chen1, Frank J Femia, John W Babich, Jon Zubieta.   

Abstract

The reaction of [ReOCl(3)(PPh(3))(2)] with salicylaldehyde-2-mercaptoanil (1) in methanol yields [ReO(OCH(3))(PPh(3))(eta(3)-OC(6)H(4)CH=NC(6)H(4)S)] (3). Reaction of 3 with 2-(2-hydroxyphenyl)benzothiazole (2) produces [ReO(eta(3)-OC(6)H(4)CH=NC(6)H(4)S)( eta(2)-OC(6)H(4))] (4) in good yield. Compound 4 may also be prepared directly from the reaction of [ReOCl(3)(PPh(3))(2)] with excess 1, after prolonged reaction times in the presence of atmospheric oxygen. The structure of 3 exhibits a distorted octahedral Re(V) center coordinated to a terminal oxo-group, a methoxy ligand, a triphenylphosphine ligand, and the N, O and S donors of the tridentate Schiff base ligand. The octahedral geometry of 4 is defined by the terminal oxo-group, the N, O and S donors of the tridentate Schiff base ligand, and the N and O donors of the bidentate 2-(2-hydroxophenyl)benzothiazole ligand. Oxidation and cyclization of the Schiff base salicylaldehyde-2-mercaptoanil to produce 2-(2-hydroxyphenyl)benzothiazole is precedented and in this instance may be driven by the formation of the robust '3+2' complex 4.

Entities:  

Year:  2000        PMID: 20617115      PMCID: PMC2898268          DOI: 10.1016/s0020-1693(00)00191-2

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  6 in total

1.  Therapeutic radiopharmaceuticals.

Authors:  W A Volkert; T J Hoffman
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-04-20       Impact factor: 2.545

3.  Bis(ligand) Rhenium(V) and Technetium(V) Complexes of Two Naturally Occurring Binding Moieties (Oxazoline and Thiazoline).

Authors:  Ed Shuter; H. R. Hoveyda; Veranja Karunaratne; Steven J. Rettig; Chris Orvig
Journal:  Inorg Chem       Date:  1996-01-17       Impact factor: 5.165

Review 4.  Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.

Authors:  P A Schubiger; R Alberto; A Smith
Journal:  Bioconjug Chem       Date:  1996 Mar-Apr       Impact factor: 4.774

5.  Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.

Authors:  J P DiZio; R Fiaschi; A Davison; A G Jones; J A Katzenellenbogen
Journal:  Bioconjug Chem       Date:  1991 Sep-Oct       Impact factor: 4.774

Review 6.  Therapeutic radionuclides: production and decay property considerations.

Authors:  W A Volkert; W F Goeckeler; G J Ehrhardt; A R Ketring
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

  6 in total
  3 in total

1.  Schiff base chemistry of the rhenium(V)-oxo core with '3+2' ligand donor sets.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2001-05       Impact factor: 2.545

2.  Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-09-11       Impact factor: 2.545

3.  Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2001-04-27       Impact factor: 2.545

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.